Taking into account the previous findings, it is crucial to investigate the molecule signature of hypoglycemia and the expression of hypothalamic miRNAs, FOS and FTO simultaneously to propose novel biomarkers for HAAF. The gene discussed is FOS; the disease is Hypoglycemia.